SG Americas Securities’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $123K | Sell |
7,216
-8,822
| -55% | -$150K | ﹤0.01% | 2260 |
|
2025
Q1 | $313K | Buy |
16,038
+3,920
| +32% | +$76.5K | ﹤0.01% | 1939 |
|
2024
Q4 | $301K | Buy |
12,118
+1,971
| +19% | +$49K | ﹤0.01% | 1574 |
|
2024
Q3 | $249K | Sell |
10,147
-8,995
| -47% | -$221K | ﹤0.01% | 2045 |
|
2024
Q2 | $448K | Buy |
19,142
+13,018
| +213% | +$305K | ﹤0.01% | 1571 |
|
2024
Q1 | $202K | Sell |
6,124
-8,720
| -59% | -$288K | ﹤0.01% | 1750 |
|
2023
Q4 | $404K | Sell |
14,844
-254
| -2% | -$6.91K | ﹤0.01% | 1455 |
|
2023
Q3 | $363K | Buy |
+15,098
| New | +$363K | ﹤0.01% | 1808 |
|
2023
Q2 | – | Sell |
-16,277
| Closed | -$498K | – | 2006 |
|
2023
Q1 | $498K | Buy |
16,277
+12,090
| +289% | +$370K | 0.01% | 1572 |
|
2022
Q4 | $164K | Sell |
4,187
-3,578
| -46% | -$140K | ﹤0.01% | 2132 |
|
2022
Q3 | $370K | Sell |
7,765
-20,418
| -72% | -$973K | ﹤0.01% | 1606 |
|
2022
Q2 | $1.09M | Buy |
28,183
+22,566
| +402% | +$874K | 0.01% | 1092 |
|
2022
Q1 | $322K | Sell |
5,617
-8,985
| -62% | -$515K | ﹤0.01% | 1927 |
|
2021
Q4 | $1.16M | Sell |
14,602
-6,065
| -29% | -$483K | 0.01% | 1405 |
|
2021
Q3 | $1.8M | Buy |
20,667
+8,440
| +69% | +$734K | 0.01% | 1240 |
|
2021
Q2 | $1.57M | Buy |
12,227
+1,281
| +12% | +$165K | 0.01% | 1159 |
|
2021
Q1 | $876K | Buy |
+10,946
| New | +$876K | ﹤0.01% | 1488 |
|
2020
Q3 | – | Sell |
-6,866
| Closed | -$192K | – | 2211 |
|
2020
Q2 | $192K | Buy |
+6,866
| New | +$192K | ﹤0.01% | 2495 |
|